$AMLX SEC Filings

Filed On	Filing
07 Oct 2026	Form 4: Milne George M Jr, Director Sold 30,000 shares ($831K)
05 Oct 2026	144
14 Sep 2026	Form 4: Bedrosian Camille L, Chief Medical Officer Sold 10,028 shares ($325K)
14 Sep 2026	Form 4: Frates James M, Chief Financial Officer Sold 10,810 shares ($350K)
14 Sep 2026	Form 4: Mazzariello Gina, Chief Legal Officer Sold 9,536 shares ($310K)
14 Sep 2026	Form 4: Cohen Joshua B, Director Sold 30,464 shares ($981K)
14 Sep 2026	Form 4: Klee Justin B., Director Sold 30,464 shares ($980K)
11 Sep 2026	144
11 Sep 2026	144
11 Sep 2026	144
11 Sep 2026	144
11 Sep 2026	144
08 Sep 2026	8-K: Entry into a Material Definitive Agreement On September 8, 2026, Amylyx Pharmaceuticals, Inc. (the “Company”) entered into a Manufacturing and Supply Agreement (the “Bachem Manufacturing Agreement”) with Bachem Americas, Inc. (“Bachem”) and on September 1, 2026, the Company enter...
02 Sep 2026	Form 4: Firestone Karen, Director Received 50,000 shares by exercise or conversion ($170K)
20 Aug 2026	Form 4: Frates James M, Chief Financial Officer Received 22,807 shares as a grant or award
20 Aug 2026	Form 4: Klee Justin B., Director Received 60,039 shares as a grant or award
20 Aug 2026	Form 4: Mazzariello Gina, Chief Legal Officer Received 21,284 shares as a grant or award
20 Aug 2026	Form 4: Bedrosian Camille L, Chief Medical Officer Received 22,807 shares as a grant or award
20 Aug 2026	Form 4: Cohen Joshua B, Director Received 60,039 shares as a grant or award
20 Aug 2026	424B5

Comments